Technical Analysis for NVTA - Invitae Corporation
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 34.21 | -5.00% | -1.80 |
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Historical NVTA trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
200 DMA Resistance | Bearish | -5.00% | |
Lower Bollinger Band Walk | Weakness | -5.00% | |
Stochastic Reached Oversold | Weakness | -5.00% | |
Wide Bands | Range Expansion | -5.00% | |
Below Lower BB | Weakness | -5.00% | |
Down 3 Days in a Row | Weakness | -5.00% | |
Lower Bollinger Band Touch | Weakness | -5.00% | |
Oversold Stochastic | Weakness | -5.00% | |
Fell Below 200 DMA | Bearish | -12.37% | |
Multiple of Ten Bearish | Other | -12.37% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time | |
---|---|---|
Down 1 ATR | about 4 hours ago | |
60 Minute Opening Range Breakdown | about 4 hours ago | |
Down 10% | about 4 hours ago | |
2x Volume Pace | about 5 hours ago | |
1.5x Volume Pace | about 5 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 02/17/2021
Invitae Corporation Description
Invitae Corporation processes DNA-containing samples, analyzes information about patient-specific genetic variation, and generates test reports for physicians and their patients using an integrated portfolio of laboratory processes, software tools, and informatics capabilities. The company's product is an assay of 216 genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, and other hereditary conditions comprising 85 various genetic disorders and 17 targeted panels. It also solutions that enable sharing of genetic information consisting of Invitae Family History Tool, a Web or iPad application, which provides family history; and Clinvitae, a Web property that allows physicians or patients to look up individual genes and variants in order to find out additional genetic information. It operates in the United States, Israel, and internationally. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was founded in 2010 and is headquartered in San Francisco, California.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Cancer Biology Telemedicine Telehealth Genetics Lab Testing Medical Genetics Medical Tests Neurological Disorders Neurology Informatics Molecular Diagnostics Urological Disorders Software Tools Genetic Disorder Genetic Disorders Cardiovascular Disorders
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 61.59 |
52 Week Low | 7.415 |
Average Volume | 4,276,980 |
200-Day Moving Average | 39.36 |
50-Day Moving Average | 48.28 |
20-Day Moving Average | 46.17 |
10-Day Moving Average | 42.08 |
Average True Range | 4.01 |
ADX | 17.91 |
+DI | 16.01 |
-DI | 35.19 |
Chandelier Exit (Long, 3 ATRs ) | 43.66 |
Chandelier Exit (Short, 3 ATRs ) | 47.04 |
Upper Bollinger Band | 56.14 |
Lower Bollinger Band | 36.20 |
Percent B (%b) | -0.01 |
BandWidth | 43.20 |
MACD Line | -3.05 |
MACD Signal Line | -2.03 |
MACD Histogram | -1.027 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 43.06 | ||||
Resistance 3 (R3) | 43.51 | 41.60 | 41.89 | ||
Resistance 2 (R2) | 41.60 | 39.81 | 41.38 | 41.49 | |
Resistance 1 (R1) | 38.81 | 38.70 | 37.86 | 38.36 | 41.10 |
Pivot Point | 36.90 | 36.90 | 36.43 | 36.68 | 36.90 |
Support 1 (S1) | 34.11 | 35.11 | 33.16 | 33.66 | 30.92 |
Support 2 (S2) | 32.20 | 34.00 | 31.98 | 30.53 | |
Support 3 (S3) | 29.41 | 32.20 | 30.14 | ||
Support 4 (S4) | 28.96 |